Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Sinibaldi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Hematology & Oncology|November 6, 2022
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemiaSimona Caruso, Biagio De Angelis, Francesca Del Bufalo, et al.
Blood|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALLFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Heliyon|December 23, 2024
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational studyAngela Mastronuzzi, Rita Carsetti, Maria Antonietta De Ioris, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
Journal for Immunotherapy of Cancer|June 17, 2021
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blastsConcetta Quintarelli, Marika Guercio, Simona Manni, et al.
Frontiers in Immunology|June 12, 2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boostersEva Piano Mortari, Federica Pulvirenti, Valentina Marcellini, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Journal of Immunology Research|August 28, 2020
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"Iole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Journal of Immunology Research|April 24, 2020
Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell ImmunomonitoringIole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Hematology & Oncology|November 6, 2022
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemiaSimona Caruso, Biagio De Angelis, Francesca Del Bufalo, et al.
Blood|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALLFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Heliyon|December 23, 2024
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational studyAngela Mastronuzzi, Rita Carsetti, Maria Antonietta De Ioris, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
Journal for Immunotherapy of Cancer|June 17, 2021
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blastsConcetta Quintarelli, Marika Guercio, Simona Manni, et al.
Frontiers in Immunology|June 12, 2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boostersEva Piano Mortari, Federica Pulvirenti, Valentina Marcellini, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Journal of Immunology Research|August 28, 2020
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"Iole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Journal of Immunology Research|April 24, 2020
Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell ImmunomonitoringIole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Pageof 3